Document Page: First | Prev | Next | All | Image | This Release | Search
File: 120396_sep96_decls75_0003.txt
Subject: BIOLOGICAL WARFARE DEFENSE MEDICAL GUIDELINES
Unit: OTSG
Parent Organization: HSC
Box ID: BX003203
Folder Title: BIOLOGICAL WARFARE DEFENSE MEDICAL GUIDELINES
Document Number: 1
Folder SEQ #: 196
UNCLASSIFIED
PRIORITY T L) r.1
FADE (:)5 RHIPAAA\\,,", S E C R F T-
f-- .@ TR!f@t@fENT -
IF THE AGENT HAS EEEN ISOLATED AND IDENTIFIED. SUSCEPTIBILITY
TO CURRENT C-.I'JTIM ICROBIALS SHOULD BE DETERMINE) IN ORDER TO GUIDE
THERAPY. IF THE AGENT IS UNI:'.'NOWN@ EMPIRIC, MULTI-DRUG THERAPY
MAY SE PURSUED. CIPROFLOXACIIJ. A O.UINOLOI@T:, HAS BROAD SPECTRUM
ACTIVITY-THAT INCLUDES ANTHRAX. THE ARMED FORCES EPIDEMIOLOGY
BOARD HAS RECOMMEI'Jr)EI3 THAT EVERY -SOLDIER BE ISSUFr-l SUFFICIENT
CIPROFLOXACIN TO TREAT FOk'FIVE ]DAYS AT 500 MGM TWICE DAILY,
THIS TIME FRAME SHOULD BE SUFFICIENT TO DETERMINE WHETHER OR NOT
THERE HAS BEEN A BW ATTACK AND TO EITHER CONTINUE OR DISCONTINUE
THERAPY. SUFFICIENT SUPPLIES TO TREAT EVERY SOLDIER FOR 3C) DAYS
HAVE 85EN PROCUREE) AND ARE AVAILABLE THROUGH ROUTINE MEDICAL
SUPPLY CHANNELS. OTHER BROAD SPECTRUM AGENTS THAT ARE WELL
TOLERATED INCLUDE: THE TETRACYCLINES (DOXYCYCLINE ALSO HAS
ACTIVITY AGAINST ANTHRAX) WHICH HAVE BROAD SPECTRUM ACTIVITY
AGAINST RICKETTSIAS TO INCLUDE 0-FEVER; ERYTHROMYCIN, WHICH CAN
COVER LEGIONELLA A140 ATYPICAL PNEUMONIA AGT7NTS; AND TH@
ANTIFUNGAL AZOLES (KETOCONA@@OLE, FLUCONAZOLE) WHICH CAN COVER
HISTOPLASMOSIS AND OTHER RESPIRATORY FUNGAL AGENTS.
PRIOR TO IDENTIFICATION OF THE AGENT, A USEFUL APPROACH TO A
PAGE 06 RHIPAAA\\\\
LARGE NUMBER OF CASUALTIES WITH SIMILAR SYMPTOMS IS THE CLINICAL
MINI-TRIAL. FIRST ASSIGN SEVERAL (10 TO 2(.@) PATIENTS TO TWO
GROUPS WITH DIFFERENT COMBINATIONS OF EMPIRIC THERAPY (E.G. -
CIPROFLOXAR,IN, ERYTHROMYCIN, [::'ETOCONAZOLE VERSUS TETRACYCLINE,
ERYTHROMYCIN, FLUCONAZOLE) OR ANY COMBINATION AVAILABLE (E.G. -
SHOW
WHETHER EITHER COMBINATION IS EFFECTIVE. ONCE A RESPONSE TO A
COMBINATION OF DRUGS IS IDENTIFIED, ANOTHER MINI-TRIAL TO
IDENTIFY WHICH SINGLE DRUG OR COMBINATION IS MOST EFFECTIVE CAN
GUIDE FUTURE THERAPY. RAPID IDENTIFICATION OF THE AGENT AND ITS
SENSITIVITIES WILL GUIDE THERAPY AND COUNTERMEASURES.
3. (U) METHODS OF DIESEMINATIDI'A:
WHILE THE ROUTES BY WHICH INFECTIOUS DISEASES ARE NORMALLY
SPREAD (AIR, WATER. FOOD, INSECT VECTOR) COULD BE USEE) FOR BW
ATTACK. AEROSOLC@ SEEM THE MOST LIKELY METHOD. CONTAMINATION OF
FOOD OR WATER SUPPLIES IS FEASIBLE AS A TERRORIST ACTIVITY BUT
RELATIVELY IMPRACTICAL CONSIIDERING STANDARD WATER TREATMENT AND
FODE) FREPARATIOII PROCEDURES. TARGETING OF THESE ATTACKS WOULD
BE VERY DIFFICULT AND AFFECT A RANDOM POPULATION WITH RANDOM
RESULTS.
BT
#2@914'
UNCLASSIFIED
PRIORITY 9 - E@
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 8 f:/Week-36/BX003203/BIOLOGICAL WARFARE DEFENSE MEDICAL GUIDELINES/biological warfare defense medical guidelines:11259610131215
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = BIOLOGICAL WARFARE DEFENSE MEDICAL GUIDELINES
Folder Seq # = 196
Subject = BIOLOGICAL WARFARE DEFENSE MEDICAL GUIDELINES
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 25-NOV-1996